LeMaitre Vascular, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $100.9M | $89.2M | $78.4M | $71.1M | $64.5M | $56.7M | $57.7M | $56.1M |
| Cost of Revenue | $30.2M | $26.2M | $24.2M | $22.7M | $19.4M | $15.9M | $17.5M | $14.3M |
| Gross Profit | $70.7M | $62.9M | $54.2M | $48.4M | $45.1M | $40.9M | $40.2M | $41.7M |
| Gross Margin | 70.1% | 70.6% | 69.1% | 68.1% | 69.9% | 72.0% | 69.7% | 74.4% |
| Operating Expenses | ||||||||
| Research & Development | $6.6M | $6.1M | $5.5M | $4.7M | $5.2M | $5.1M | $4.4M | $5.5M |
| SG&A Expense | $17.0M | $14.4M | $14.0M | $13.9M | $12.6M | $11.0M | $11.2M | $10.5M |
| Operating Income | $21.1M | $16.3M | $11.5M | $6.3M | $4.5M | $4.2M | $3.7M | $4.0M |
| Operating Margin | 20.9% | 18.3% | 14.7% | 8.9% | 7.0% | 7.5% | 6.4% | 7.2% |
| Interest Expense | $21.0K | $14.0K | — | $5.0K | $12.0K | $1.0K | — | $5.0K |
| Pretax Income | $21.1M | $16.2M | $11.4M | $6.3M | $4.3M | $4.0M | $3.8M | $4.0M |
| Income Tax Expense | $3.9M | $5.7M | $3.7M | $2.4M | $1.1M | $1.4M | $1.6M | $-2.0M |
| Net Income | $17.2M | $10.6M | $7.8M | $3.9M | $3.2M | $2.6M | $2.1M | $6.0M |
| Net Margin | 17.0% | 11.9% | 9.9% | 5.5% | 5.0% | 4.5% | 3.7% | 10.7% |
| EPS (Basic) | $0.91 | $0.57 | $0.44 | $0.24 | $0.21 | $0.17 | $0.14 | $0.38 |
| EPS (Diluted) | $0.86 | $0.55 | $0.42 | $0.23 | $0.20 | $0.16 | $0.13 | $0.37 |
| Shares Outstanding (Basic) | 19.0M | 18.5M | 17.8M | 16.6M | 15.3M | 15.2M | 15.5M | 15.6M |
| Shares Outstanding (Diluted) | 20.0M | 19.2M | 18.3M | 17.0M | 15.8M | 15.6M | 16.0M | 16.1M |
| Dividends Per Share | $0.22 | $0.18 | $0.16 | $0.14 | $0.12 | $0.10 | $0.08 | — |